Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
32 pending office actions • 18 art units • 32 examiners • 0 of 32 (0%) have an AI response strategy ready • 28 patents granted in the last 365 days
The Trustees of Indiana University currently manage 30 pending office actions within the Biotechnology & Pharmaceuticals technology area. This portfolio demonstrates significant breadth across the USPTO, as these actions are distributed among 30 distinct examiners. The ratio of 30 examiners to 30 pending actions suggests a lack of examiner concentration, which may require diverse prosecution strategies tailored to individual examiner preferences. This variety in personnel means that the applicant must be prepared for a wide range of examination styles and procedural interpretations.
The portfolio spans 18 distinct art units, indicating a wide range of technical subject matter within the life sciences sector. CHRISTIAN MANUEL SARCENO ROBLES is identified as the busiest examiner for this applicant, yet they are responsible for only 1 busiest examiner pending action. This distribution highlights that no single examiner holds a significant portion of the pending workload, necessitating a broad management approach across many different USPTO divisions. Practitioners must track 18 different art units to stay aligned with the various technical standards and prior art landscapes relevant to this diverse set of applications.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (6%) |
| §103 only | 8 (25%) |
| §102 only | 2 (6%) |
| §112 only | 2 (6%) |
| Double-patenting + other | 2 (6%) |
| Multi-statute (no §101) | 16 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SARCENO ROBLES, CHRISTIAN MANUEL | 1 | 50.0% | +100.0% |
| TROCHE, EDGAREDMANUE | 1 | 57.8% | +35.0% |
| MORAN, EDWARD JOHN | 1 | 41.8% | +61.1% |
| VASISTH, VISHAL V | 1 | 72.3% | +33.4% |
| VO, HUYEN X | 1 | 83.4% | +19.9% |
| WELLS, LAUREN QUINLAN | 1 | 48.4% | +60.3% |
| JACKSON III, WALTER | 1 | 100.0% | +0.0% |
| ZHU, JIANJIAN | 1 | 58.8% | +82.4% |
| OJOFEITIMI, AYODEJI HARRY | 1 | 89.2% | +3.9% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.0% | +18.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18886296 | METHOD AND APPARATUS FOR ENCODING/DECODING NEURAL NETWORK-BASED PERSONALIZED SPEECH | VO, HUYEN X | — |
| 18835051 | A METHOD FOR RAPID GENERATION OF 3D ORGANOTYPIC CELL CLUSTERS | JACKSON III, WALTER | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042931 | METHODS TO PREVENT HIGH-GRADE SEROUS OVARIAN CANCER AND BREAST CANCER BY ADMINISTERING ANTIPROGESTINS | GAUGER, PAUL RANDALL | 37d overdue |
| 18262799 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | HUMPHRIES, NICHOLAS ADAM | 8d overdue |
| 18027476 | FOXP3S-PROMOTING MORPHOLINOS | MEYERING, SHABANA SHABBEER | 5d overdue |
| 18040834 | IN VIVO LYMPHOVENOUS ANASTOMOSIS | SHIN, DANA H | 9d |
| 17791981 | SYSTEM AND METHOD FOR PROCESSING VIRUS PREPARATIONS TO REDUCE HETEROGENEITY | SIFFORD, JEFFREY MARK | 16d |
| 18541121 | POTENTIATING THE TUMOR-SELECTIVE EFFECTS OF NQO1-BIOACTIVATABLE AGENT BY USE OF CMET INHIBITOR | ARCORIA, PAUL JOSEPH | 28d |
| 19083739 | HAND-HELD MEASUREMENT APPARATUS, SYSTEMS, AND METHODS | SARCENO ROBLES, CHRISTIAN MANUEL | — |
| 18927321 | SYSTEMS AND METHODS FOR MONITORING AND CONTROLLING ADDITIVE PRINTING PROCESSES | TROCHE, EDGAREDMANUE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18913249 | DENTAL IMPLANTS, DENTAL ASSEMBLIES, AND METHODS OF IMPLANTING AND REPAIRING DENTAL ASSEMBLIES | MORAN, EDWARD JOHN | 33d |
| 19083739 | HAND-HELD MEASUREMENT APPARATUS, SYSTEMS, AND METHODS | SARCENO ROBLES, CHRISTIAN MANUEL | — |
| 18927321 | SYSTEMS AND METHODS FOR MONITORING AND CONTROLLING ADDITIVE PRINTING PROCESSES | TROCHE, EDGAREDMANUE | — |
| 18851829 | CYTOCOMPATIBLE HYDROGELS AND METHODS OF MAKING AND USING THE SAME | VASISTH, VISHAL V | — |
| 18886296 | METHOD AND APPARATUS FOR ENCODING/DECODING NEURAL NETWORK-BASED PERSONALIZED SPEECH | VO, HUYEN X | — |
| 18794321 | METHODS TO TREAT RENAL DISORDERS USING CALCIUM CHANNEL INHIBITORS | WELLS, LAUREN QUINLAN | — |
| 18716889 | METHODS OF GENERATING HUMAN COCHLEAR HAIR CELLS | ZHU, JIANJIAN | — |
| 18699774 | METHOD OF REGULATING PULMONARY ARTERY VASCULAR REMODELING | POLIAKOVA-GEORGAN, EKATERINA | — |
| Art Unit | Apps |
|---|---|
| 1621 | 2 |
| 1635 | 2 |
| 1744 | 1 |
| 3772 | 1 |
| 2656 | 1 |
| 1653 | 1 |
| 1658 | 1 |
| 1655 | 1 |
| 1675 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19083739 | HAND-HELD MEASUREMENT APPARATUS, SYSTEMS, AND METHODS | SARCENO ROBLES, CHRISTIAN MANUEL | — | §102§103§112 | Non-Final OA | — | Pending | Mar 19, 2025 |
| 18927321 | SYSTEMS AND METHODS FOR MONITORING AND CONTROLLING ADDITIVE PRINTING PROCESSES | TROCHE, EDGAREDMANUE | 1744 | §102§103§112 | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18913249 | DENTAL IMPLANTS, DENTAL ASSEMBLIES, AND METHODS OF IMPLANTING AND REPAIRING DENTAL ASSEMBLIES | MORAN, EDWARD JOHN | 3772 | §112 | Final Rejection | 33d | Pending | Oct 11, 2024 |
| 18851829 | CYTOCOMPATIBLE HYDROGELS AND METHODS OF MAKING AND USING THE SAME | VASISTH, VISHAL V | — | §103DP | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18886296 | METHOD AND APPARATUS FOR ENCODING/DECODING NEURAL NETWORK-BASED PERSONALIZED SPEECH | VO, HUYEN X | 2656 | §103 | Final Rejection | — | Pending | Sep 16, 2024 |
| 18794321 | METHODS TO TREAT RENAL DISORDERS USING CALCIUM CHANNEL INHIBITORS | WELLS, LAUREN QUINLAN | — | §102 | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18835051 | A METHOD FOR RAPID GENERATION OF 3D ORGANOTYPIC CELL CLUSTERS | JACKSON III, WALTER | — | §103 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18716889 | METHODS OF GENERATING HUMAN COCHLEAR HAIR CELLS | ZHU, JIANJIAN | — | §103§112 | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18649689 | ANIMAL DRUG DELIVERY SYSTEM AND METHOD | OJOFEITIMI, AYODEJI HARRY | — | §103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18699774 | METHOD OF REGULATING PULMONARY ARTERY VASCULAR REMODELING | POLIAKOVA-GEORGAN, EKATERINA | — | §102§103§112 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18694650 | DEPLETION OF FNDC5 REDUCES CANCER INDUCED MUSCLE LOSS/CACHEXIA | CHONG, KIMBERLY | — | §102§112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18691513 | ZWITTERIONIC SURFACES FOR LOCALIZED SURFACE PLASMON RESONANCE | RILEY, JEZIA | — | §102§103§112 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18599502 | TARGETS AND BIOMARKERS FOR TUMOR MICROENVIRONMENTS | BOWERS, ERIN M | 1653 | §102§103DP | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18688475 | COMPOSITION AND METHOD TO TREAT CACHEXIA | DACE DENITO, ALEXANDRA GERALDINE | — | §102§103§112 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18294722 | EPIGENETIC MODULATORS FOR TISSUE REPROGRAMMING | RYAN, DOUGLAS CHARLES | — | §102§103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18575429 | CXC CHEMOKINE AGONISTS AND ANTAGONISTS IN COVID-19 DISEASE AND DIAGNOSTIC ASSAYS | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18262798 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | BOECKELMAN, JACOB A | 1655 | §101§102§103§112 | Final Rejection | — | Pending | Dec 21, 2023 |
| 18541121 | POTENTIATING THE TUMOR-SELECTIVE EFFECTS OF NQO1-BIOACTIVATABLE AGENT BY USE OF CMET INHIBITOR | ARCORIA, PAUL JOSEPH | 1621 | §102§103§112 | Non-Final OA | 28d | Pending | Dec 15, 2023 |
| 18535605 | ULTRA-HIGH SPECIFIC ENERGY CATHODE MATERIALS FOR LITHIUM-ION BATTERIES AND METHODS FOR PRODUCING THE SAME | RASSOULI, LILI | — | §103§112 | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18546910 | METABOLIC BIOMARKERS FOR ASSESSING HEART FAILURE IN A SINGLE VENTRICLE PEDIATRIC SUBJECT | CHERNYSHEV, OLGA N | 1675 | §112 | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18262799 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103 | Final Rejection | 8d overdue | Pending | Jul 25, 2023 |
| 18272455 | A DEVICE HAVING A SUPPORT STRUCTURE FOR CREATING A HOLLOW, THREE-DIMENSIONAL ORGANOIDS AND CULTURES | LOPEZLIRA, ASHLEY NICOLE | 1799 | §103 | Final Rejection | — | Pending | Jul 14, 2023 |
| 18261451 | METHODS TO PREDICT EFFECTS OF PERIOPERATIVE ADMINISTRATION OF METHADONE TO OPTIMIZE PAIN RELIEF AND AVOID ADVERSE EFFECTS | GOLDBERG, JEANINE ANNE | 1682 | §101§103§112 | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18260115 | TOCOTRIENOL COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC STEATOHEPATITIS | KOSTURKO, GEORGE W | 1621 | §103 | Final Rejection | 14d | Pending | Jun 30, 2023 |
| 18027476 | FOXP3S-PROMOTING MORPHOLINOS | MEYERING, SHABANA SHABBEER | 1635 | §103§112 | Final Rejection | 5d overdue | Pending | Mar 21, 2023 |
| 18042931 | METHODS TO PREVENT HIGH-GRADE SEROUS OVARIAN CANCER AND BREAST CANCER BY ADMINISTERING ANTIPROGESTINS | GAUGER, PAUL RANDALL | 1629 | §102§103 | Final Rejection | 37d overdue | Pending | Feb 24, 2023 |
| 18041241 | QUORUM SENSING INHIBITORS AND METHODS OF USE | OTTON, ALICIA L | 1699 | §102 | Non-Final OA | — | Pending | Feb 10, 2023 |
| 18040834 | IN VIVO LYMPHOVENOUS ANASTOMOSIS | SHIN, DANA H | 1635 | §103§112 | Final Rejection | 9d | Pending | Feb 07, 2023 |
| 17966286 | MAPPING CRITICAL BRAIN SITES USING INTRACRANIAL ELECTROPHYSIOLOGY AND MACHINE LEARNING | JASANI, ASHISH SHIRISH | 3798 | §103 | Non-Final OA | — | Pending | Oct 14, 2022 |
| 17937136 | SEI PREFORMED GRAPHITE AND ASSOCIATED METHODS, APPARATUS, AND PRODUCTS | JACOBSON, SARAH JORDAN | 1785 | §103 | Non-Final OA | — | Pending | Sep 30, 2022 |
| 17870785 | N-PROPANOL/H2O MIXED SOLVENT COMPOSITIONS FOR MEMBRANE ELECTRODE ASSEMBLIES | LYNCH, VICTORIA HOM | 1724 | §103 | Final Rejection | 163d overdue | Pending | Jul 21, 2022 |
| 17791981 | SYSTEM AND METHOD FOR PROCESSING VIRUS PREPARATIONS TO REDUCE HETEROGENEITY | SIFFORD, JEFFREY MARK | 1671 | §103§112 | Final Rejection | 16d | Pending | Jul 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial